CSL · 1 day ago
Executive or Senior Director Search & Evaluation Late TA Lead
Greater Philadelphia
Full-time
Hybrid
Director/Executive
15+ years expCSL is a biotech company focused on delivering impactful therapies for patients. They are seeking an Executive or Senior Director of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external clinical assets in Immunology, Hematology, and Cardiovascular/Renal therapeutic areas while managing a team of TA Leads.
BiotechnologyHealth CareHealth DiagnosticsMedical
Hiring Manager
Jamie O'Malley
Responsibilities
Lead and manage a team of early and late-stage Search & Evaluation TA Leads
Develop the strategy and a consistent process for all Search & Evaluation activities
Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning
Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs
Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations
Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics
Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy
Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions
Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution
Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities
Qualification
Required
15+ years in biopharma with significant experience in clinical development, external innovation, or business development
Advanced degree required (MD, PhD, or equivalent)
Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas
Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks
Strong understanding of regulatory pathways, market access, and competitive standards of care
Experience leading a global team
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Leadership Team
Jeffrey Ball
Chief Sustainability Officer
Joy Linton
Strategic Advisor
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase